Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 7;13(1):512.
doi: 10.1186/s13104-020-05363-0.

A snapshot of Plasmodium falciparum malaria drug resistance markers in Sudan: a pilot study

Affiliations

A snapshot of Plasmodium falciparum malaria drug resistance markers in Sudan: a pilot study

Nouh S Mohamed et al. BMC Res Notes. .

Abstract

Objectives: Malaria infection is still known to be a worldwide public health problem, especially in tropical and sub-tropical African countries like Sudan. A pilot study conducted to describe the trend of P. falciparum drug resistance markers in 2017-2018 in comparison to CQ and AS/SP eras in Sudan. The Pfcrt, Pfmdr-1, Pfdhfr, and Pfdhps genes were investigated. Data deposited by the worldwide antimalarial resistance network was consulted, and the molecular markers previously reported from Sudan were analyzed.

Results: Drug molecular markers analysis was successfully done on 20 P. falciparum isolates. The Pfcrt K76 showed high frequency; 16 (80%). For the Pfmdr-1, 9 (45%) isolates were carrying the N86 allele, and 11 (55%) were 86Y allele. While the Y184F of the Pfmdr-1 showed a higher frequency of 184F compared to Y184; 16 (80%) and 4 (20%), respectively. In the Pfdhfr, 51I allele showed higher frequency compared to N51; 18 (90%) and 2 (10%), respectively. For S108N, 18 (90%) were 108 N and 2 (10%) were S108. In the Pfdhps, all isolates were carrying the mutant alleles; 437G and 540E. The frequency distribution of the Pfcrt, Pfmdr-1, Pfdhfr, Pfdhps was significantly different across the whole years in Sudan.

Keywords: Molecular markers; Multi drug resistance; Plasmodium falciparum; Sudan.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Frequency distribution of single Pfcrt K76T and Pfmdr-1 N86Y genotypes in 2017–2018 samples compared with previously published reports
Fig. 2
Fig. 2
Frequency distribution of double haplotypes of Pfdhfr N51I and S108N, and Pfdhps A437G and K540E in 2017–2018 samples compared with previously published reports

References

    1. WHO: World malaria report 2019. Geneva: World Health Organization 2019.
    1. Kouznetsov R, Rooney W, Wernsdorfer W, El Gaddal A, Payne D, Abdalla R. Assessment of the sensitivity of Plasmodium falciparum to antimalarial drugs at Sennar, Sudan: use of the in vitro micro-technique and the in vivo method. Geneva: World Health Organization; 1979. - PMC - PubMed
    1. Malik EM, Khalafalla O. Malaria in Sudan: past, present and the future. Gezira J Health Sci. 2004;1:1–9.
    1. Sudan Malaria Diagnosis and Treatment Protocol. 2017. https://reliefweb.int/report/sudan/sudan-malaria-diagnosis-and-treatment...). Accessed 2 July 2020.
    1. Adam I, Ibrahim M, Aelbasit I, El Bashir M. Efficacy of sulfadoxine/pyrimethamine for uncomplicated Plasmodium falciparum malaria in a small sample of Sudanese children. pp 309–314, 2004. - PubMed